植物乳杆菌GKM3益生菌对高脂饮食肥胖大鼠之影响
Effect of Lactobacillus plantarum GKM3 on Obesity in High-Fat Diet-Induced Rats
DOI: 10.12677/HJFNS.2017.62009, PDF, HTML, XML,  被引量 下载: 2,421  浏览: 6,024 
作者: 林诗伟, 王启宪, 陈炎炼：葡萄王生技股份有限公司，台湾 桃园；孙至柔, 张维棠：中山医学大学营养学系，台湾 台中；赵 敞：上海葡萄王企业有限公司，上海；徐庆琳：中山医学大学营养学系，台湾 台中；中山医学大学附设医院营养科，台湾 台中；陈劲初：葡萄王生技股份有限公司，台湾 桃园；国立台湾大学食品科技研究所，台湾 台北；彰化师范大学生物技术研究所，台湾 彰化；中原大学生物科技学系，台湾 桃园
关键词: 植物乳杆菌 GKM3；益生菌；肥胖；体脂；尿酸；Lactobacillus plantarum GKM3； Probiotics； Obesity； Body Fat； Uric Acid
摘要: 高油脂饮食已经被证实造成许多肥胖相关疾病之发生，例如：第二型糖尿病、脑中风、心血管疾病、脂肪肝、肠癌、高血压与高血脂症等。本研究以分离自台湾产腌制酸菜中的植物乳杆菌GKM3益生菌冻干粉末喂食高脂饮食诱导Wistar大鼠，探讨其对体脂肪、体重及血液生化分析之影响。试验大鼠分为三组，分别正常组(ND)喂食正常饲料，高脂饲料组(HFD)及高脂饲料管喂给予GKM3益生菌组(HFD + GKM3)。结果显示给予GKM3可显著抑制高脂饮食诱导之体重增加，抑制肝脏的肿大、降低内脏脂肪与体脂肪堆积、降低血清中三酸甘油酯与尿酸浓度、降低肝脏中脂质含量及提高粪便中脂质含量(p < 0.05)。
Abstract: High fat diet has been confirmed to cause many obesity-related diseases, such as type 2 diabetes, stroke, cardiovascular disease, fatty liver, colon cancer, hypertension and hyperlipidemia. The aim of this study was to evaluate the effects of Lactobacillus plantarum GKM3, separated from sauerkraut in Taiwan, on body fat, body weight and blood biochemical in Wistar rats fed a high fat diet. The rats were randomly divided into three groups, normal diet (ND) group, high fat diet (HFD) group, and high-fat diet with probiotic GKM3 (HFD + GKM3) group. The results showed that GKM3 could significantly inhibit the weight of body and liver, reduce the accumulation of visceral fat and body fat, decrease the concentration of triglyceride and uric acid in the serum, and decrease the lipid contents in the liver and the stool. Based on the above results, GKM3 can beneficially affect the host by reducing the detrimental effects induced by a high-fat diet (p < 0.05).
文章引用：林诗伟, 孙至柔, 张维棠, 王启宪, 赵敞, 陈炎炼, 徐庆琳, 陈劲初. 植物乳杆菌GKM3益生菌对高脂饮食肥胖大鼠之影响[J]. 食品与营养科学, 2017, 6(2): 85-95. https://doi.org/10.12677/HJFNS.2017.62009

参考文献

[1] Yang, L. and Colditz, G.A. (2015) Prevalence of Overweight and Obesity in the United States. JAMA Internal Medicine, 175, 1412-1413.
https://doi.org/10.1001/jamainternmed.2015.2405
[2] Van Gaal, L.F., Mertens, I.L. and De Block, C.E. (2006) Mechanisms Linking Obesity with Cardiovascular Disease. Nature, 444, 875-880.
https://doi.org/10.1038/nature05487
[3] Park, D.Y., Ahn, Y.T., Huh, C.S., Jeon, S.M. and Choi, M.S. (2011) The Inhibitory Effect of Lactobacillus plantarum KY1032 Cell Extract on the Adipogenesis of 3T3-L1 Cells. Journal of Medicinal Food, 14, 670-675.
https://doi.org/10.1089/jmf.2010.1355
[4] Weisberg, S.P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I. and Leibel, R.L. (2006) CCR2 Modulates Inflammatory and Metabolic Effects of High-Fat Feeding. Journal of Clinical Investigation, 116, 115-124.
https://doi.org/10.1172/JCI24335
[5] McKane, W.R., Stevens, A.B., Woods, R., Andrews, W.J., Henry, R.W. and Bell, P.M. (1990) The Assessment of Hepatic and Peripheral Insulin Sensitivity in Hypertriglyceridemia. Metabolism, 39, 1240-1245.
[6] Eckel, R.H., Barouch, W.W. and Ershow, A.G. (2002) Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease. Circulation, 105, 2923-2929.
https://doi.org/10.1161/01.CIR.0000017823.53114.4C
[7] Chen, M., Wang, M.C., Ni, R., Wang, J., Wang, L., Wang, G.N. and Zhang, L.Y. (2017) Role of Probiotics in Treatment of Nonalcoholic Fatty Liver Disease. Chinese Journal of Hepatology, 25, 77-80.
[8] Wanless, I.R. and Lentz, J.S. (1990) Fatty Liver Hepatitis (Steatohepatitis) and Obesity: An Autopsy Study with Analysis of Risk Factors. Hepatology, 12, 1106-1110.
https://doi.org/10.1002/hep.1840120505
[9] Saadeh, S. (2007) Nonalcoholic Fatty Liver Disease and Obesity. Nutrition in Clinical Practice, 22, 1-10.
https://doi.org/10.1177/011542650702200101
[10] Venkatesan, S. and Simpson, K.J. (1989) Fatty Liver and Plasma Corticosterone Levels in Chronically Alcohol- and Pair-Fed Rats. Biochemical Society Transactions, 17, 1114-1115.
https://doi.org/10.1042/bst0171114
[11] Sowers, J.R. (2003) Obesity as a Cardiovascular Risk Factor. American Journal of Medicine, 115, 37S-41S.
[12] Mcternan, C.L., Mcternan, P.G., Harte, A.L., Levick, P.L., Barnett, A.H. and Kumar, S. (2002) Resistin, Central Obesity, and Type 2 Diabetes. The Lancet, 359, 46-47.
[13] Barton, M., Carmona, R., Morawietz, H., d’Uscio, L.V., Goettsch, W., Hillen, H., Haudenschild, C.C., Krieger, J.E., Munter, K., Lattmann, T., Luscher, T.F. and Shaw, S. (2000) Obesity Is Associated with Tissue-Specific Activation of Renal Angiotensin-Converting Enzyme in Vivo: Evidence for a Regulatory Role of Endothelin. Hypertension, 35, 329- 336.
https://doi.org/10.1161/01.HYP.35.1.329
[14] Hall, J.E., Kuo, J.J., da Silva, A.A., de Paula, R.B., Liu, J. and Tallam, L. (2003) Obesity-Associated Hypertension and Kidney Disease. Current Opinion in Nephrology and Hypertension, 12, 195-200.
https://doi.org/10.1097/00041552-200303000-00011
[15] Mai, V., Colbert, L.H., Berrigan, D., Perkins, S.N., Pfeiffer, R., Laviqne, J.A., Lanza, E., Haines, D.C., Schatzkin, A. and Hursting, S.D. (2003) Calorie Restriction and Diet Composition Modulate Spontaneous Intestinal Tumorigenesis in (Apc) Min Mice through Different Mechanisms. Cancer Research, 63, 1752-1755.
[16] Zhang, J., Xiao, X., Dong, Y., Xu, T. and Wu, F. (2016) Dietary Supplementation with Lactobacillus plantarum dy-1 Fermented Barley Suppresses Body Weight Gain in High-Fat Diet-Induced Obese Rats. Journal of the Science of Food and Agriculture, 96, 4907-4917.
https://doi.org/10.1002/jsfa.7786
[17] Tzang, B.S., Yang, S.F., S.G., Yang, H.C., Sun, H.L. and Chen, Y.C. (2009) Effects of Dietary Flaxseed Oil on Cholesterol Metabolism of Hamsters. Food Chemistry, 144, 1450-1455.
[18] Bray, G.A. and Bouchard, C. (2014) Handbook of Obesity: Clinical AHPP-Glications. 4th Edition, Vol. 2.
[19] Large, V., Peroni, O., Letexier, D., Ray, H. and Beylot, M. (2004) Metabolism of Lipids in Human White Adipocyte. Diabetes & Metabolism, 30, 294-309.
[20] Yao, Y., Li, X.B., Zhao, W., Zeng, Y.Y., Shen, H., Xiang, H. and Xiao, H. (2010) Anti-Obesity Effect of an Isoflavone Fatty Acid Ester on Obese Mice Induced by High Fat Diet and Its Potential Mechanism. Lipids in Health and Disease, 9, 49.
https://doi.org/10.1186/1476-511X-9-49
[21] Misra, A. and Vikram, N. (2003) Clinical and Pathophysiological Consequences of Abdominal Adiposity and Abdominal Adipose Tissue Depots. Nutrition, 19, 457-466.
[22] Takemura, N., Okubo, T. and Sonoyama, K. (2010) Lactobacillus Plantarum Strain No. 14 Reduces Adipocyte Size in Mice Fed High-Fat Diet. Experimental Biology and Medicine, 235, 849-856.
https://doi.org/10.1258/ebm.2010.009377
[23] Gomes, N.D., de, C.M.M., Soares, M.M., Dos, A.B.L., de, S.D.M., Machado, R.R.S. and Stampini, D.M.H. (2016) Ubá Mango Juices Intake Decreases Adiposity and Inflammation in High-Fat Diet-Induced Obese Wistar Rats. Nutrition, 32, 1011-1018.
[24] Roch-Ramel, F., Werner, D. and Guisan, B. (1994) Urate Transport in Brush-Border Membrane of Human Kidney. American Journal of Physiology, 266, F797-F805.